Who owns Cytosorbents?
- Ticker: CTSO
- CUSIP Number: 23283x206
Tip: Access positions for across all investors
Analyze quarterly positions in Cytosorbents with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cytosorbents stock
Who bought or sold Cytosorbents this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Avenir Corporation | 3.2M | $3.0M | 4% | Mar 2024 |
|
| Granahan Investment Management | 3.0M | $2.9M | 96% | Mar 2024 |
|
| Skylands Capital | 2.9M | $2.7M | -12% | Mar 2024 |
|
| Vanguard Group | 1.9M | $1.9M | 0% | Mar 2024 |
|
| Neuberger Berman Group | 1.9M | $1.8M | 6% | Mar 2024 |
|
| Sargent Investment Group | 1.4M | $1.3M | 4% | Mar 2024 |
|
| CM Management | 825k | $784k | 99% | Mar 2024 |
|
| BlackRock | 722k | $686k | -1% | Mar 2024 |
|
| Geode Capital Management | 438k | $417k | 20% | Mar 2024 |
|
| Atlantic Trust | 173k | $157k | 41% | Mar 2024 |
|
| Morgan Stanley | 116k | $111k | -6% | Mar 2024 |
|
| Advisor Group Holdings | 114k | $108k | 1% | Mar 2024 |
|
| Northern Trust | 75k | $71k | 0% | Mar 2024 |
|
| Raymond James Financial Services Advisors | 61k | $58k | 0% | Mar 2024 |
|
| Raymond James & Associates | 50k | $48k | 0% | Mar 2024 |
|
| Jane Street | 47k | $44k | 100% | Mar 2024 |
|
| Stifel Financial | 45k | $43k | 0% | Mar 2024 |
|
| Bank of America Corporation | 37k | $35k | -45% | Mar 2024 |
|
| Millennium Management | 36k | $34k | -21% | Mar 2024 |
|
| Key Client Fiduciary Advisors | 35k | $33k | 188% | Mar 2024 |
|
| Chicago Partners Investment | 31k | $27k | -1% | Mar 2024 |
|
| Texas Capital Bank Wealth Management Services | 23k | $22k | -24% | Mar 2024 |
|
| Creative Planning | 21k | $20k | 0% | Mar 2024 |
|
| Johnson Investment Counsel | 19k | $18k | -3% | Mar 2024 |
|
| Granite Springs Asset Management | 19k | $18k | 0% | Mar 2024 |
|
| Susquehanna International | 16k | $15k | 100% | Mar 2024 |
|
| Country Club Bank | 15k | $15k | 0% | Mar 2024 |
|
| Resources Investment Advisors | 15k | $14k | 0% | Mar 2024 |
|
| Sei Investments | 15k | $14k | 5% | Mar 2024 |
|
| Regal Investment Advisors | 12k | $11k | -50% | Mar 2024 |
|
| Bradley, Foster & Sargent | 10k | $11k | 0% | Dec 2023 |
|
| Tower Research Capital | 8.0k | $7.6k | 899% | Mar 2024 |
|
| Bank of New York Mellon | 3.6k | $3.5k | -84% | Mar 2024 |
|
| Hexagon Capital Partners | 3.3k | $3.2k | 0% | Mar 2024 |
|
| SOA Wealth Advisors | 2.2k | $2.1k | 0% | Mar 2024 |
|
| Lazard Asset Management | 938.00 | $1.0k | 100% | Dec 2023 |
|
| Brian McDonald | 837.00 | $794.982600 | 224% | Mar 2024 |
|
| Wells Fargo & Company | 796.00 | $757.792000 | 47% | Mar 2024 |
|
| Simplex Trading | 620.00 | $0 | -58% | Mar 2024 |
|
| Jpmorgan Chase & Co | 372.00 | $352.990800 | 0% | Mar 2024 |
|
| Your Advocates | 250.00 | $238.000000 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 93.00 | $0 | 18% | Mar 2024 |
|
| UBS Group | 57.00 | $54.001800 | -98% | Mar 2024 |
|
| Hanson McClain Advisors | 37.00 | $36.001000 | 0% | Mar 2024 |
|
| Pnc Financial Services | 31.00 | $29.000500 | -14% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 3.00 | $3.000000 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 1.00 | $1.000000 | 0% | Mar 2024 |
|
Who sold out of Cytosorbents?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Dimensional Fund Advisors | Dec 2023 | 57k | $63k |
| Virtu Financial | Dec 2023 | 20k | $22k |
| Charles Schwab Investment Management | Dec 2023 | 16k | $18k |
| Us Bancorp | Dec 2023 | 10k | $11k |
| Advisory Services Network | Dec 2023 | 2.2k | $2.4k |